Report Highlights
Key Questions Answered in this Report:
- What are the major market drivers, challenges, and opportunities in the U.S. hematologic malignancies testing market?
- What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market?
- Which is the dominant product type developed by the leading and emerging players for the diagnosis of hematologic malignancies?
- What are the key technologies that have been used by leading players in the U.S. market for the development of diagnostic solutions for hematologic malignancies?
- How each segment of the market is expected to grow during the forecast period from 2019 to 2025 based on:
- product type
- disease
- technology
- end user
- country, i.e., U.S.
- Which companies are anticipated to be highly disruptive in the future and why?
- What are the reimbursement scenario and the regulations for the development of diagnostic solutions for the diagnosis of hematologic malignancies, specifically in the U.S.?
U.S. Hematologic Malignancies Market Forecast
The U.S. hematologic malignancies market analysis by BIS Research projects the market to grow at a significant CAGR of 14.60% during the forecast period, 2019-2025. The U.S. hematologic malignancies market generated $723.9 million revenue in 2018, in terms of value.
The U.S. hematologic malignancies market growth has been primarily attributed to the major drivers in this market, such as rising incidence of hematologic malignancies, favorable reimbursement scenario, and increase in funding in the hematologic malignancies market. However, there are factors hindering the growth of the market, such as lack of training professionals, high pricing pressure, and issue pertaining to the analytic validity of genetic testing.
Expert Quote
In an era of precision and increasingly personalized therapy, the healthcare industry demands cost-effective options that can robustly identify biomarkers to help select cancer patients most likely to benefit from the emerging class of immuno-oncology drug.
Scope of the Market Intelligence on the U.S. Hematologic Malignancies Market
The U.S. hematologic malignancies market research provides a holistic view of the market in terms of various factors influencing it, including strategic developments and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with industrial and biological research. In addition, the study also includes exhaustive information on unmet needs, perception on new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the U.S. hematologic malignancies market.
Market Segmentation
The U.S. hematologic malignancies market (on the basis of product type) is segmented into kits and services.
The U.S. hematologic malignancies market (on the basis of technology) is segmented into polymerase chain reaction, next-generation sequencing, fluorescence in-situ hybridization, immunohistochemistry, flow-cytometry, and other technologies.
The U.S. hematologic malignancies market (on the basis of disease) is segmented into leukemia, lymphoma, multiple myeloma, myeloproliferative neoplasms, and myelodysplastic syndromes.
The U.S. hematologic malignancies market (on the basis of end user) is segmented into specialty clinics and hospitals, research institutions, reference laboratories, diagnostic laboratories, and other end users.
Key Companies in the U.S. Hematologic Malignancies Market
The key manufacturers that have been contributing significantly to the U.S. hematologic malignancies market includes Abbott Laboratories, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Corporation, Cancer Genetics Inc., QIAGEN N.V., ICON plc, Quest Diagnostics Incorporated, Invitae Corporation, Opkp Health, Laboratory Corporation of American Holdings, NeoGenomics Laboratories, Inc., ASURAGEN, INC., ArcherDX, Inc., Adaptive Biotechnologies, ARUP Laboratories, and Invivoscribe, Inc, among others.
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More